Ultivue announces launch of new configurable multiplex spatial panels at the Society for Immunotherapy of Cancer 2023 meeting

Ultivue Logo

Oct 30, 2023

CAMBRIDGE, Mass., Oct. 30, 2023 /PRNewswire/ — Ahead of the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC), Ultivue today announced the launch of OmniVUE™, a unique portfolio of fully customizable biomarker panels for multiplex immunofluorescence analysis of the tumor immune microenvironment. Researchers can now select any combination of up to 8 biomarkers from Ultivue’s validated biomarker core library and design OmniVUE panels tailored to their specific biological questions. Pre-optimized ready-to-use kits with OmniVUE panels will be delivered within four weeks of request, with no additional development costs.  

Read the full article on PR Newswire. 


Share this page on social

Ready to get started? See what Samba can do for you.